仙乐健康(300791)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300791 仙乐健康

已收盘 11-15 15:00:00

{"stockData":{"symbol":"300791","market":"SZ","secType":"STK","nameCN":"仙乐健康","latestPrice":26.6,"timestamp":1731654213000,"preClose":27.53,"halted":0,"volume":2762300,"delay":0,"floatShares":194000000,"shares":236000000,"eps":1.4232,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.93,"latestTime":"11-15 15:00:00","open":27.37,"high":27.67,"low":26.6,"amount":75126000,"amplitude":0.0389,"askPrice":26.61,"askSize":50,"bidPrice":26.6,"bidSize":144,"shortable":0,"etf":0,"ttmEps":1.4232,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":27.53,"symbolType":"stock","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":30.28,"lowLimit":24.78,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":235872880,"pbRate":2.92,"roa":"--","roe":"9.83%","epsLYR":1.5585,"committee":0.068627,"marketValue":6274000000,"floatMarketCap":5170000000,"peRate":18.690275,"changeRate":-0.0338,"turnoverRate":0.0142,"status":1},"requestUrl":"/m/hq/s/300791","defaultTab":"news","newsList":[{"id":"2481114929","title":"11月7日仙乐健康涨7.00%，融通先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481114929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481114929?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:22","pubTimestamp":1730967737,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日仙乐健康涨7.00%，收盘报28.9元，换手率4.11%，成交量7.99万手，成交额2.28亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为融通先进制造混合A。融通先进制造混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","399260","BK0226"],"gpt_icon":0},{"id":"2481929460","title":"仙乐健康涨7.00%，太平洋一周前给出“买入”评级，目标价34.68元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481929460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481929460?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:22","pubTimestamp":1730967724,"startTime":"0","endTime":"0","summary":"今日仙乐健康涨7.00%，收盘报28.9元。2024年10月29日，太平洋研究员郭梦婕,肖依琳发布了对仙乐健康的研报《仙乐健康：国内需求疲软拖累整体表现，海外延续高增态势》，该研报对仙乐健康给出“买入”评级，认为其目标价为34.68元，现价距离目标价尚有20.00%的涨幅空间。仙乐健康个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","601099"],"gpt_icon":0},{"id":"2480287153","title":"仙乐健康：渠道结构调整拖累中国业务节奏 龙头格局优化长期趋势不改","url":"https://stock-news.laohu8.com/highlight/detail?id=2480287153","media":"长江证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480287153?lang=zh_cn&edition=full","pubTime":"2024-11-04 13:24","pubTimestamp":1730697847,"startTime":"0","endTime":"0","summary":"事件描述仙乐健康公布2024 年三季报。事件评论l 中国市场渠道调整致业务承压，海外业务维持高增。l 毛利率波动或为单季度影响，前三季度费用率相对稳健。公司2024Q3 毛利率下行，预计主要系订单达成的季度影响和部分区域的订单结构拖累，财务费用增加预计主要系可转债利息、外部借款利息及汇兑损益影响。l 短期来看，在国内保健品市场药店渠道调整及线上增长进一步加速的背景下，公司海外及国内业务表现分化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104132409a2137057&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104132409a2137057&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0195","300791","BK0188","000860","BK0028","000860.SH","BK0226","BK0215"],"gpt_icon":0},{"id":"2480027590","title":"仙乐健康（300791）11月1日主力资金净买入1042.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480027590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480027590?lang=zh_cn&edition=full","pubTime":"2024-11-01 15:21","pubTimestamp":1730445669,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月1日收盘，仙乐健康报收于26.46元，上涨1.61%，换手率2.09%，成交量4.05万手，成交额1.06亿元。11月1日的资金流向数据方面，主力资金净流入1042.29万元，占总成交额9.81%，游资资金净流出590.32万元，占总成交额5.56%，散户资金净流出451.97万元，占总成交额4.25%。仙乐健康主营业务：主要从事营养保健食品的研发、生产、销售及技术服务。该股最近90天内共有18家机构给出评级，买入评级14家，增持评级4家；过去90天内机构目标均价为33.45。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100022655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2479103487","title":"仙乐健康：10月30日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479103487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479103487?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:06","pubTimestamp":1730344017,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月30日仙乐健康发布公告称公司于2024年10月30日召开业绩说明会。仙乐健康主营业务：主要从事营养保健食品的研发、生产、销售及技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100019216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2479496100","title":"太平洋：给予仙乐健康买入评级，目标价位34.68元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479496100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479496100?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:55","pubTimestamp":1730163318,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司郭梦婕,肖依琳近期对仙乐健康进行研究并发布了研究报告《仙乐健康：国内需求疲软拖累整体表现，海外延续高增态势》，本报告对仙乐健康给出买入评级，认为其目标价位为34.68元，当前股价为27.85元，预期上涨幅度为24.52%。我们按照2025年业绩给17倍PE，一年目标价为34.68元。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.47。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","601099"],"gpt_icon":0},{"id":"2478488717","title":"仙乐健康：10月25日高管姚壮民增持股份合计2000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2478488717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478488717?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:01","pubTimestamp":1730120465,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月28日市场公开信息、上市公司公告及交易所披露数据整理，仙乐健康（300791）最新董监高及相关人员股份变动情况：2024年10月25日公司董事,高管姚壮民共增持公司股份2000.0股，占公司总股本为0.0008%。变动期间公司股价下跌0.75%，10月25日当日收盘报26.6元。仙乐健康近半年内的董监高及核心技术人员增减持详情如下：仙乐健康的高管列表及最新持股情况如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.47。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800031397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2478936038","title":"华金证券给予仙乐健康买入评级 国内需求边际承压 夯实内功静待改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2478936038","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478936038?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:36","pubTimestamp":1729863360,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 华金证券10月25日发布研报称，给予仙乐健康（300791.SZ，最新价：26.6元）买入评级。评级理由主要包括：1）事件：公司发布2024年三季度报告；2）收入分析：预计国内边际承压，海外如期快增。风险提示：市场需求变化，行业竞争加剧，渠道拓展不及预期，客户拓展不及预期等。AI点评：仙乐健康近一个月获得5份券商研报关注，买入5家，平均目标价为34.5元，与最新价26.6元相比，高7.9元，目标均价涨幅29.7%。（文章来源：每日经济新闻）\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-25/doc-inctuumr4619709.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-25/doc-inctuumr4619709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","300791"],"gpt_icon":0},{"id":"2478593366","title":"华金证券：给予仙乐健康买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478593366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478593366?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:35","pubTimestamp":1729863324,"startTime":"0","endTime":"0","summary":"华金证券股份有限公司李鑫鑫,王颖近期对仙乐健康进行研究并发布了研究报告《国内需求边际承压，夯实内功静待改善》，本报告对仙乐健康给出买入评级，当前股价为26.6元。　　仙乐健康　　事件：公司发布2024年三季度报告。Q3公司营收增速环比放缓至10.4%，主要系国内业务拖累。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.47。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500045116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","161027"],"gpt_icon":0},{"id":"2478676875","title":"仙乐健康（300791）10月25日主力资金净卖出780.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478676875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478676875?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:22","pubTimestamp":1729840932,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月25日收盘，仙乐健康报收于26.6元，下跌0.75%，换手率3.31%，成交量6.43万手，成交额1.7亿元。10月25日的资金流向数据方面，主力资金净流出780.16万元，占总成交额4.58%，游资资金净流入1638.14万元，占总成交额9.62%，散户资金净流出857.97万元，占总成交额5.04%。仙乐健康主营业务：主要从事营养保健食品的研发、生产、销售及技术服务。该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.47。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500020108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2478973386","title":"仙乐健康（300791）2024年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478973386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478973386?lang=zh_cn&edition=full","pubTime":"2024-10-25 06:09","pubTimestamp":1729807742,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期仙乐健康发布2024年三季报。截至本报告期末，公司营业总收入30.48亿元，同比上升21.8%，归母净利润2.4亿元，同比上升29.52%。按单季度数据看，第三季度营业总收入10.58亿元，同比上升10.43%，第三季度归母净利润8532.83万元，同比上升1.63%。本报告期仙乐健康应收账款上升，应收账款同比增幅达78.99%。持有仙乐健康最多的基金为东海消费臻选混合发起式A，目前规模为0.13亿元，最新净值0.96，较上一交易日下跌1.36%，近一年下跌2.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500005324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791"],"gpt_icon":0},{"id":"2477896696","title":"华鑫证券：给予仙乐健康买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477896696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477896696?lang=zh_cn&edition=full","pubTime":"2024-10-24 19:20","pubTimestamp":1729768828,"startTime":"0","endTime":"0","summary":"华鑫证券有限责任公司孙山山,张倩近期对仙乐健康进行研究并发布了研究报告《公司事件点评报告：中国区订单边际承压，精益降本持续推进》，本报告对仙乐健康给出买入评级，当前股价为26.8元。　　仙乐健康　　事件　　2024年10月23日，仙乐健康发布2024年三季度报告。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.47。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400032501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","161027"],"gpt_icon":0},{"id":"2477526475","title":"东吴证券：给予仙乐健康买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477526475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477526475?lang=zh_cn&edition=full","pubTime":"2024-10-24 13:15","pubTimestamp":1729746924,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司孙瑜,罗影近期对仙乐健康进行研究并发布了研究报告《2024年Q3业绩点评：中国区降速拖累业绩表现，积极调整应对渠道变革》，本报告对仙乐健康给出买入评级，当前股价为26.98元。其中BF前三季度同比增长接近40%。这共同导致了导致中国区收入Q3环比降速。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.95。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400018048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300791"],"gpt_icon":0},{"id":"2477510897","title":"仙乐健康：有知名机构彤源投资，星石投资参与的多家机构于10月23日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477510897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477510897?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:02","pubTimestamp":1729735353,"startTime":"0","endTime":"0","summary":"海外仍将维持较好增势，内生业务仍维持利润率稳定，BF 环比改善。2025年利润增速预算内部制定中，请留意公司后续披露的信息。中国区同类型客户毛利率同比仍然保持稳定。该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.95。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400010702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2477308055","title":"仙乐健康最新公告：第三季度净利润8532.83万元 同比增长1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477308055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477308055?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:31","pubTimestamp":1729697461,"startTime":"0","endTime":"0","summary":"仙乐健康发布2024年第三季度报告，公司前三季度实现营业收入30.48亿元，同比增长21.80%；实现归属于上市公司股东的净利润2.4亿元，同比增长29.52%。其中，第三季度实现营业收入10.58亿元，同比增长10.43%；实现归属于上市公司股东的净利润8532.83万元，同比增长1.63%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300038422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791"],"gpt_icon":0},{"id":"2477158307","title":"仙乐健康(300791.SZ)发布前三季度业绩，净利润2.4亿元，同比增长29.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477158307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477158307?lang=zh_cn&edition=full","pubTime":"2024-10-23 18:57","pubTimestamp":1729681047,"startTime":"0","endTime":"0","summary":"智通财经APP讯，仙乐健康(300791.SZ)发布2024年第三季度报告，公司前三季度营业收入30.48亿元，同比增长21.80%;归属于上市公司股东的净利润2.4亿元，同比增长29.52%;归属于上市公司股东的扣除非经常性损益的净利润2.36亿元，同比增长28.11%;基本每股收益1.34元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300791"],"gpt_icon":0},{"id":"2475254357","title":"仙乐健康（300791）10月15日主力资金净卖出522.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475254357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475254357?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:26","pubTimestamp":1728977205,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月15日收盘，仙乐健康报收于26.72元，下跌4.5%，换手率1.96%，成交量3.81万手，成交额1.04亿元。10月15日的资金流向数据方面，主力资金净流出522.49万元，占总成交额5.04%，游资资金净流入494.52万元，占总成交额4.77%，散户资金净流入27.98万元，占总成交额0.27%。仙乐健康主营业务：主要从事营养保健食品的研发、生产、销售及技术服务。该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为33.97。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500018482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2473442211","title":"仙乐健康最新公告：2024年第三季度取得发明专利证书和保健食品注册证书、备案凭证","url":"https://stock-news.laohu8.com/highlight/detail?id=2473442211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473442211?lang=zh_cn&edition=full","pubTime":"2024-10-08 18:35","pubTimestamp":1728383721,"startTime":"0","endTime":"0","summary":"仙乐健康公告，公司在2024年第三季度取得5项发明专利证书（其中3项中国发明专利，2项日本发明专利）和6项保健食品备案凭证；公司全资子公司广东仙乐取得1项发明专利证书（为中国发明专利）；全资子公司安徽仙乐取得5项保健食品备案凭证。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800028829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2470747297","title":"9月27日仙乐健康涨6.04%，融通先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470747297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470747297?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:13","pubTimestamp":1727428419,"startTime":"0","endTime":"0","summary":"证券之星消息，9月27日仙乐健康涨6.04%创60日新高，收盘报26.85元，换手率1.86%，成交量3.61万手，成交额9554.52万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为融通先进制造混合A。融通先进制造混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700026330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226","399260"],"gpt_icon":0},{"id":"2470775200","title":"天风证券：给予仙乐健康买入评级，目标价位34.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470775200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470775200?lang=zh_cn&edition=full","pubTime":"2024-09-26 17:27","pubTimestamp":1727342862,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司吴立,陈潇近期对仙乐健康进行研究并发布了研究报告《外延并购助力全球化发展，境外业务实现高增》，本报告对仙乐健康给出买入评级，认为其目标价位为34.50元，当前股价为25.32元，预期上涨幅度为36.26%。最新盈利预测明细如下：该股最近90天内共有16家机构给出评级，买入评级13家，增持评级3家；过去90天内机构目标均价为33.7。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600025937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","300791"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-09-25","address":"广东省汕头市龙湖区泰山路83号","stockEarnings":[{"period":"1week","weight":-0.0561},{"period":"1month","weight":-0.0075},{"period":"3month","weight":0.0884},{"period":"6month","weight":-0.1282},{"period":"1year","weight":0.0747},{"period":"ytd","weight":0.0298}],"companyName":"仙乐健康科技股份有限公司","boardCode":"AI0014","perCapita":"21953股","boardName":"食品制造业","registeredCapital":"23587万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":"　　仙乐健康科技股份有限公司主营业务是提供营养保健食品领域一家集研发、生产、销售、技术服务为一体的综合服务。公司产品涵盖鱼油系列、Ω369系列、氨糖系列、钙产品系列、维生素和矿物质系列、辅酶Q10系列、葡萄籽等植物提取物系列等。公司在营养健康食品行业内拥有广泛知名度。","serverTime":1731820574373,"listedPrice":54.73,"stockholders":"8854人(较上一季度增加15.02%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仙乐健康(300791)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仙乐健康(300791)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仙乐健康,300791,仙乐健康股票,仙乐健康股票老虎,仙乐健康股票老虎国际,仙乐健康行情,仙乐健康股票行情,仙乐健康股价,仙乐健康股市,仙乐健康股票价格,仙乐健康股票交易,仙乐健康股票购买,仙乐健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仙乐健康(300791)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仙乐健康(300791)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}